Observational studyJournal of clinical hypertension (Greenwich, Conn.)2026
The Serum Testosterone Level in Male Patients Is Inversely Associated With Hypertension Incidence.
Observational study in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hypertension is a primary risk factor for cardiovascular diseases and all-cause mortality. Testosterone, the most potent androgen in males, regulates reproduction, metabolism, and erythropoiesis. Hypertension incidence increases with age, whereas testosterone levels decline. Thus, we conducted a study to explore the association between the two events and the predictive role of serum testosterone for hypertension. Among 3480 male patients aged ≥40 years who visited the Cardiovascular Medicine Center of our hospital, 3401 were eligible for the study. Linear relationships, generalized additive models, multivariate regression, and the data's receiver operating characteristic (ROC) curves were constructed and analyzed. These male patients were consecutively admitted to our Cardiovascular Medicine Center during a 4-year period. We found that hypertensive patients aged between ≥40 and <80 years had significantly lower serum testosterone levels than the normotensive ones. A multivariate regression model showed an inverse association between serum testosterone levels and hypertension in these patients. As expected, there was a significant correlation between age and testosterone levels. ROC curve analysis revealed that serum testosterone had a modest predictive role for hypertension in male patients aged between 40 and 60 years. For those aged between 60 and 79 years, a combination of testosterone, age, smoking status, and body mass index (BMI) improved a predictive value for hypertension. This observational study demonstrates that in aged male patients, testosterone levels were inversely proportional to hypertension. In some age groups, they had an improved predictive value for hypertension when combined with other clinical factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.